A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough

A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough

Abstract Hydrocodone/chlorpheniramine is a prescription opioid licensed in the USA for the relief of cough and upper respiratory symptoms associated with allergy or cold in adults, previously contraindicated in children aged < 6 years. We present findings from a modern benefit risk review of hydr...

Full description

Bibliographic Details
Main Authors: Victor S. Sloan, Alphia Jones, Chidi Maduka, Jürgen W. G. Bentz
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-05-01
Series:Drugs - Real World Outcomes
Online Access:http://link.springer.com/article/10.1007/s40801-019-0152-6

Internet

http://link.springer.com/article/10.1007/s40801-019-0152-6

Similar Items